Swiss Alpinopharma GmbH, a subsidiary of MediCrops AG, is an innovative HealthTech scale-up focused on providing direct access to cannabis-based medicines for patients in Germany. The company is at the beginning of an exciting growth phase, aiming to build scalable and automated patient communication systems. With a commitment to patient-centered care, Swiss Alpinopharma is dedicated to shaping the digital future of cannabis therapy through efficient and structured processes.